Of those never having undergone RRBSO, a slightly higher proportion of controls had breast cancer (BRCA1 60.1%, BRCA2 60.4%) and chemotherapy (51.4%/45.4%) (Table 2). This evidence concerns the gene BRCA1 and breast cancer.